Cell Oncol (Dordrecht) (2015) 38(5):36575
They are neither approved nor intended for: Human consumption Cosmetic or topical application Tanning purposes Pharmaceutical or medical applications Veterinary use The content on this page reflects current scientific research and literature
LIRA and SEMA gained approval from the Food and Drug Administration and the European Medicines Agency for weight loss in obese individuals or people who are overweight with BMI 27 kg/m 2 and have experienced at least one weight-associated comorbid condition (such as prediabetes, hypertension, dyslipidaemia, and OSA) combined with lifestyle modifications [63]
GLP-1 receptor agonists and the thyroid: c-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation
Pluskal, T., Hayashi, T., Saitoh, S., Fujisawa, A